Corinna Schlosser

I specialize in innovations, inventions, inventors, patent attorneys, assignees and patents.

Title: The Innovator: Corinna Schlosser Revolutionizing Cancer Treatment

Introduction:

Corinna Schlosser, a distinguished inventor based in Freising, DE, is making waves in the field of biomedical research with his groundbreaking patents. With a keen focus on developing anti-cancer treatments, Schlosser has emerged as a leading figure in the fight against cancer.

Latest Patents:

Schlosser's most recent patents include a series of anti-cancer fusion polypeptides capable of binding both CD137 and glypican-3 (GPC3). These fusion polypeptides exhibit great potential in targeting and activating immune responses specifically towards GPC3-positive tumor cells. The applications of these fusion polypeptides extend to various pharmaceutical realms, serving as potent anti-cancer agents and immune modulators for combating a wide range of tumors.

Career Highlights:

Currently affiliated with Pieris Pharmaceuticals GmbH, Schlosser has solidified his place as a key figure within the company's research division. His innovative work has led to the development of cutting-edge therapies that have the potential to revolutionize cancer treatment paradigms. Schlosser's dedication to advancing medical science underscores his commitment to making a tangible difference in the lives of patients battling cancer.

Collaborations:

In his professional journey, Schlosser has collaborated closely with esteemed colleagues such as Marlon Hinner and Rachida Siham Bel Aiba. Their collective efforts have paved the way for the successful creation and application of novel fusion polypeptides that hold immense promise in the realm of cancer therapeutics.

Conclusion:

Corinna Schlosser's relentless pursuit of scientific excellence and his unwavering commitment to combating cancer through innovative means exemplify his status as a visionary inventor. With a stellar track record of impactful patents and a collaborative spirit that drives meaningful progress, Schlosser stands at the forefront of shaping the future of cancer treatment.